Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
27.76
+0.28 (1.02%)
Feb 3, 2026, 3:04 PM CST

SHE:300357 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
1,0551,1191,171840.69649.99583.68
Trading Asset Securities
286.82196.09117.39295.05370.93307.03
Cash & Short-Term Investments
1,3421,3151,2891,1361,021890.71
Cash Growth
7.22%2.03%13.47%11.25%14.62%12.44%
Accounts Receivable
346.17251.04202.92254.31238.12206.77
Other Receivables
6.2--19.8111.138.57
Receivables
352.38251.04202.92274.12249.26215.35
Inventory
53.757.7359.0448.4153.7548.33
Other Current Assets
24.327.7819.1718.8617.5816.55
Total Current Assets
1,7721,6511,5701,4771,3421,171
Property, Plant & Equipment
852.98780.09704.84444.61301.62240.16
Long-Term Investments
77.2677.9474.2178.483.3513.86
Other Intangible Assets
151.86162.79161.38139.679461.01
Long-Term Deferred Tax Assets
6.785.65.034.875.814.9
Long-Term Deferred Charges
28.4225.2734.3853.286.05113.89
Other Long-Term Assets
3.65.9412.42-19.63-
Total Assets
2,8932,7092,5622,1981,9321,605
Accounts Payable
36.0347.777.997.685.085.66
Accrued Expenses
26.9935.1333.5729.8935.5423.15
Short-Term Debt
512.6334.39---
Current Portion of Leases
4.685.036.83.985.86-
Current Income Taxes Payable
33.5110.569.2626.0850.329.59
Current Unearned Revenue
0.630.510.380.420.420.44
Other Current Liabilities
13.170.9584.6434.7110.7816.57
Total Current Liabilities
119.95182.58177.04102.7510855.42
Long-Term Leases
9.727.9321.2612.281.95-
Long-Term Unearned Revenue
32.2233.5330.9327.4324.9120.63
Long-Term Deferred Tax Liabilities
0.090.170.20.080.50.56
Other Long-Term Liabilities
-26.0829.0328.22--
Total Liabilities
161.98250.3258.46170.76135.3676.61
Common Stock
523.58523.58523.58523.58523.58523.58
Additional Paid-In Capital
128.19128.19128.19128.19128.19128.19
Retained Earnings
1,9841,7021,5331,3281,084803.26
Comprehensive Income & Other
0.030.040.030.0300.87
Total Common Equity
2,6362,3542,1851,9801,7361,456
Minority Interest
95.49105.12118.6147.4960.5472.24
Shareholders' Equity
2,7312,4592,3042,0271,7971,528
Total Liabilities & Equity
2,8932,7092,5622,1981,9321,605
Total Debt
19.3925.5962.4416.267.81-
Net Cash (Debt)
1,3231,2891,2261,1191,013890.71
Net Cash Growth
10.13%5.14%9.54%10.50%13.74%12.44%
Net Cash Per Share
2.532.462.342.141.931.70
Filing Date Shares Outstanding
523.58523.58523.58523.58523.58523.58
Total Common Shares Outstanding
523.58523.58523.58523.58523.58523.58
Working Capital
1,6521,4691,3931,3741,2341,116
Book Value Per Share
5.034.504.173.783.322.78
Tangible Book Value
2,4842,1912,0241,8401,6421,395
Tangible Book Value Per Share
4.744.183.873.513.142.66
Buildings
-428.52423.31175.67137.89137.89
Machinery
-135.42115.9995.5177.1171.89
Construction In Progress
-323.16227.86226.24140.3380.46
Source: S&P Global Market Intelligence. Standard template. Financial Sources.